David Harper

David Harper

Company: Evolution Biotechnologies

Job title: CEO


Panel Discussion: Overcoming Barriers in Securing Funding & Questioning the Investment Process…Worth Billions or Nothing? 11:00 am

Explaining the sudden dry up of funds Learning how investors value an early-stage phage business that could make or break it Understanding what makes an attractive proposition when looking at investing in life science phage therapies How does funding capital differ for different bacteriophage therapiesRead more

day: Day Two

Discussing the Selection of Disease Targets for Bacteriophages 1:30 pm

Accessibility and suitability of the bacterial target Identification and selection of bacteriophages Commercial considerations in the selection of targetsRead more

day: Day One

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.